Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Healthcare, Education, Latest News, Research

    Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study

    January 26, 2026 ayushis Comments Off on Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    Two surgeons wearing surgical masks and caps focus intently on a procedure under bright operating room lights, with another medical professional visible in the background.
    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care.

    Synovial sarcoma most often develops in the extremities, but in rare cases, it can arise in the head and neck region. A published case study in the European Archives of Oto-Rhino-Laryngology highlights one such rare presentation: monophasic synovial sarcoma originating in the posterior pharyngeal wall.

    Although uncommon, head and neck synovial sarcoma presents unique diagnostic and treatment challenges due to the complexity of surrounding anatomy and the critical functions involved in breathing, swallowing, and speech. Studies like this one provide valuable insight for clinicians and patients navigating these rare diagnoses.

    A rare and challenging diagnosis

    In this case, a 25-year-old patient presented with symptoms including difficulty breathing while lying down, snoring, and trouble swallowing solid foods. Initial imaging and biopsy suggested a benign tumor, a situation that is not uncommon with synovial sarcoma due to its tendency to appear well-defined and non-aggressive on early scans.

    As symptoms progressed, further imaging and pathology revealed the diagnosis of monophasic synovial sarcoma of the posterior pharyngeal wall. This highlights a known challenge with synovial sarcoma: it can closely mimic benign conditions, leading to delays in diagnosis, particularly in rare anatomical locations like the head and neck.

    Imaging and pathology findings

    Advanced imaging showed a heterogeneous mass with areas of calcification—an imaging feature seen in a subset of synovial sarcoma cases. Definitive diagnosis was confirmed through histopathology, immunohistochemistry, and cytogenetic testing, which identified the characteristic t(X;18) chromosomal translocation associated with synovial sarcoma.

    The tumor was classified as monophasic, meaning it consisted primarily of spindle-shaped cells, a subtype that is frequently misdiagnosed due to its resemblance to other soft tissue tumors.

    Surgical treatment and reconstruction

    The primary treatment approach was wide surgical excision aimed at achieving clear margins. Due to the tumor’s size and location, the surgery required complex access and reconstruction. The surgical team used a lateral trapezius flap—a less commonly used reconstructive technique—to repair the defect created after tumor removal.

    This reconstructive approach allowed restoration of the pharyngeal wall while preserving critical structures involved in swallowing and airway protection. The study highlights this technique as a potential option for large defects in similar cases.

    Role of additional therapies

    Following surgery, the patient received radiation therapy. Chemotherapy was initiated but discontinued after one cycle due to side effects. At follow-up, the patient showed no evidence of disease and was able to resume oral intake with supportive therapy.

    While the role of chemotherapy in head and neck synovial sarcoma remains debated, studies suggest that a multidisciplinary approach—including surgery, radiation, and careful long-term surveillance—offers the best chance for disease control.

    Why this study matters

    Although this case represents a single patient, it adds to a limited body of knowledge about synovial sarcoma in the head and neck region. For patients and families affected by synovial sarcoma outside of the extremities, studies like this help improve understanding of how the disease can present, how it is diagnosed, and what treatment options may look like.

    Importantly, it also reinforces the value of second opinions, specialized pathology review, and care at centers experienced with sarcoma—especially when symptoms persist despite reassurance that a mass may be benign.

    Looking ahead

    Head and neck synovial sarcoma remains rare, but continued documentation and study are essential to improving diagnosis, treatment strategies, and long-term outcomes. Research like this contributes to ongoing efforts to refine surgical techniques, explore reconstruction options, and better understand the biology of this complex disease.

    For patients navigating synovial sarcoma of the head and neck, awareness and advocacy remain critical tools—both for timely diagnosis and access to specialized care.

    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care. Original study here.

    For more detailed information about Synovial Sarcoma resources and support, please visit our website.

    ayushis

    Post navigation

    Previous

    Search

    Categories

    • Black Flag Racing (2)
    • CHOP (3)
    • Development (2)
    • Dr. Theodore Laetsch (3)
    • Education (3)
    • Healthcare (3)
    • Latest News (7)
    • Research (12)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • Two surgeons wearing surgical masks and caps focus intently on a procedure under bright operating room lights, with another medical professional visible in the background.
      Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    • A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
      UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma
    • Close-up of a gloved hand adjusting the focus knobs on a laboratory microscope, with lens details visible and a specimen slide illuminated on the stage.
      Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Community Engagement & Partnerships Manager Conference Dr. Rachel Hurly Dr. Ted Laetsch Dr. Theodore W. Laetsch fibroblast fibroblast epigenome grant ground breaking human cell therapy immune-cell therapy JAMA Internal Medicine Julie Kramer MAGE-A4 Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications Patient Stories Pediatric Oncology Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma SUMO2 inhibitors Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TAK-981 TCR-NK TCR Therapy TECELRA Zelluna ZI-MA4-1

    Related posts

    A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
    Healthcare, Latest News, Research

    UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    January 21, 2026 ayushis Comments Off on UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    UI Health Care has begun treating eligible patients with synovial sarcoma using a new form of immunotherapy known as T cell receptor (TCR) therapy. This treatment approach represents an important step forward in expanding access to innovative options for people facing advanced synovial sarcoma. A targeted immune-based approach TCR therapy is designed to help the […]

    Close-up of a gloved hand adjusting the focus knobs on a laboratory microscope, with lens details visible and a specimen slide illuminated on the stage.
    Latest News, Research

    Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    January 12, 2026 ayushis Comments Off on Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    Researchers have studied prasterone—also known as DHEA (dehydroepiandrosterone)—as a potential treatment option for people with synovial sarcoma that has spread (metastatic) or cannot be removed through surgery. This clinical study was designed to better understand the safety of prasterone, determine appropriate dosing, and explore whether it could help slow or control disease progression. This trial […]

    A woman with short brown hair smiles at the camera outdoors. She is wearing a black sweater and a dark top, with light makeup and a natural background behind her.
    Latest News, Synovial Sarcoma Registry

    Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    December 23, 2025 ayushis Comments Off on Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome our 100th registrant. This achievement signifies the growing commitment to advancing research and improving treatment options for patients with synovial sarcoma. The registry serves as a pivotal resource, collecting invaluable data and biospecimens from patients […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch